Cardlytics, Inc. Common Stock
CDLX
Positions held
Your positionsCDLX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $11.48M | Enterprise value | $173.33M | Trailing P/E | — | Forward P/E | -0.59 |
| PEG | — | Price / book | -0.71 | Beta | 0.72 | Dividend yield | 0.00% |
| Revenue growth | -36.5% | Earnings growth | — | Gross margin | 48.9% | Operating margin | -14.8% |
| Profit margin | -52.8% | ROE | -5.1% | ROA | -7.4% | Debt / equity | — |
| Current ratio | 1.62 | Free cash flow | $13.79M | Analyst recommendation | none | Mean target | $6.00 |
| 52w high | $22.06 | 52w low | $1.83 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $36.9M | $34.3M | $56.1M | $52.0M | $58.0M | — |
| Op margin | -14.8% | -24.1% | -7.3% | -18.6% | -16.1% | — |
| Net income | -$14.9M | -$4.5M | -$8.3M | -$72.7M | -$9.3M | — |
| Gross margin | 50.5% | 49.9% | 46.2% | 46.7% | 44.7% | — |
| Gross profit | $18.6M | $17.1M | $25.9M | $24.3M | $26.0M | — |
| Operating income | -$5.4M | -$8.3M | -$4.1M | -$9.7M | -$9.3M | — |
- Revenue +7% vs prior quarter ($37M vs $34M).
- Gross margin 50.5% (was 50% prior quarter).
- Operating margin expanded to -14.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $233M | $278M | $309M | $299M |
| Op margin | -19.6% | -22.8% | -20.6% | -45.4% |
| Net income | -$103M | -$189M | -$135M | -$465M |
| Gross margin | 44.8% | 43.4% | 42.2% | 37.7% |
| Gross profit | $105M | $121M | $130M | $113M |
| Operating income | -$45.7M | -$63.5M | -$63.7M | -$136M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Cardlytics and Rove Team Up to Help Travelers Earn Their Next Trip Faster
2026-09-24 · Similarweb stock falls after naming new CEO
2026-09-24 · Similarweb Names Michael Akkerman Chief Executive
2026-08-13 · Cardlytics (CDLX) Q2 2026 Earnings Call Transcript
2026-08-06 · Cardlytics, Inc. Q2 2026 Earnings Call Summary
2026-08-05 · Cardlytics: Q2 Earnings Snapshot
2026-08-05 · Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
2026-08-03 · Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-07-31 · Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-07-29 · Cardlytics Appoints Chris Cheng as Chief Legal Officer
2026-07-21 · Cardlytics to Report Second Quarter 2026 Results on August 5
Price (daily)
Full chart · RSI · MACD · patterns